My Watchlist
Create Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Colossal Biosciences
Colossal Celebrates the First Birthday of Romulus & Remus
October 01, 2025
From
Colossal Biosciences
Via
Business Wire
Colossal Advances Dodo De-Extinction with Significant, World’s First Breakthrough in Pigeon PGCs and Secures an Additional $120M in Funding for Species Expansion
September 17, 2025
From
Colossal Biosciences
Via
Business Wire
World-Leading Developmental Biologist Andrew Pask, Ph.D Joins Colossal Full-time as Chief Biology Officer
August 20, 2025
From
Colossal Biosciences
Via
Business Wire
The Ngāi Tahu Research Centre Has Entered Into a Strategic Partnership With De-Extinction Company, Colossal Biosciences, and Sir Peter Jackson, to Resurrect the South Island Giant Moa and Other Taonga Species
July 08, 2025
From
Colossal Biosciences
Via
Business Wire
Colossal Announces World’s First De-Extinction: Birth of Dire Wolves
April 07, 2025
From
Colossal Biosciences
Via
Business Wire
Colossal Creates the Colossal Woolly Mouse, Showcasing Breakthroughs in Multiplex Genome Editing and Trait Engineering on the Path to a Mammoth
March 04, 2025
From
Colossal Biosciences
Via
Business Wire
Colossal Secures $200M in Series C Funding From TWG Global on the Back of Numerous World’s First Scientific Breakthroughs on Path to De-Extinction
January 15, 2025
From
Colossal Biosciences
Via
Business Wire
Colossal Launches The Colossal Foundation
October 01, 2024
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences’ Thylacine Gene-Editing Technologies Provide Hope for Australia’s Endangered Northern Quoll
May 08, 2024
From
Colossal Biosciences
Via
Business Wire
Plastic Degradation Company, Breaking, Emerges from Stealth with Naturally-Derived Solution to Degrade Multiple Plastics with $10.5M in Seed Funding
April 17, 2024
From
Colossal Biosciences
Via
Business Wire
Re:wild and Colossal Biosciences team up to leverage revolutionary technology to save critically endangered species on the brink of extinction
March 28, 2024
From
Colossal Biosciences
Via
Business Wire
World-Renowned Ancient DNA Expert, HHMI Investigator, and MacArthur Award Winner Beth Shapiro, Ph.D., Joins Colossal as Chief Science Officer
March 19, 2024
From
Colossal Biosciences
Via
Business Wire
Revolutionary Elephant iPSC Milestone Reached in Colossal’s Woolly Mammoth Project
March 06, 2024
From
Colossal Biosciences
Via
Business Wire
Oscar-Award Winning ‘My Octopus Teacher’ Nature Documentarian James Reed to Make Docuseries About De-Extinction Company Colossal, to be Produced by Underdog Films and Teton Ridge Entertainment
February 21, 2024
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences Names Emily Castel as Chief Marketing Officer
February 01, 2024
From
Colossal Biosciences
Via
Business Wire
Colossal Announces the Tasmania Thylacine Advisory Committee
December 20, 2023
From
Colossal Biosciences
Via
Business Wire
Mauritian Wildlife Foundation Partners With Colossal Biosciences to Rewild the Dodo to Its Native Habitat
November 22, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences and Save the Elephants Debut First-of-its-Kind Project to Utilize Drones and Machine Learning for Elephant Conservation
November 09, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences Joins BioRescue in Its Mission to Save the Northern White Rhino From Extinction
September 19, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences “Mammoth in the Classroom” Initiative, as Part of University of Alaska Fairbanks Adopt a Mammoth Program, Has Reached Its Initial Research and Adoption Goal
August 21, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences Launches Partnership with Elephant Havens Wildlife Foundation to Develop New Models for the Successful Reintroduction of Orphan Elephants Using AI
July 19, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences Named to TIME’s List of the TIME100 Most Influential Companies
June 21, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences and the Vertebrate Genomes Project Publish the First Near Complete African Elephant Chromosome Level Genome
May 18, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences Secures $150M Series B and Announces Plan to De-Extinct the Iconic Dodo
January 31, 2023
From
Colossal Biosciences
Via
Business Wire
Colossal Accelerates Research and Development of Life-Saving Vaccine to Prevent Elephant Extinction
October 05, 2022
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences Spins Out Form Bio to Revolutionize Computational Life Sciences
September 27, 2022
From
Colossal Biosciences
Via
Business Wire
Colossal to De-Extinct the Thylacine, also known as the Tasmanian Tiger, an Iconic Australian Marsupial That Has Been Extinct Since 1936
August 16, 2022
From
Colossal Biosciences
Via
Business Wire
Colossal Biosciences and the Vertebrate Genomes Project Sequence the Asian Elephant Genome, Chromosome to Chromosome
July 12, 2022
From
Colossal Biosciences
Via
Business Wire
Colossal Named a Technology Pioneer by World Economic Forum
May 10, 2022
From
Colossal Biosciences
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.